U.S. Representative, District 18 from New York
Patrick Kevin Ryan is an American businessman, politician, and former U.S. Army intelligence officer serving as the U.S. representative for New York's 18th congressional district since 2023. A member of the Democratic Party, he previously served as the representative for New York's 19th congressional district from 2022 to 2023 after being elected in a special election. Before being elected to the House, he was the county executive of Ulster County, New York.
Source: Wikipedia (CC BY-SA 4.0)| Date ▼ | Ticker ↕ | Asset | Type ↕ | Amount ↕ | Filed After ↕ |
|---|---|---|---|---|---|
| 2024-07-31 | -- | OnSolve LLC Shares | Sell | $15K - $50K | 436d |
Itemized FEC receipts to the member's committee. Transfers from their own committees, party money, self-funding, and processors such as ActBlue and WinRed are excluded.
EMPIRE STATE STRIKES BACK
$148.8K
4 donations
DEMOCRATIC FUTURE LEADERSHIP FUND
$59.0K
2 donations
SERVE AMERICA VICTORY FUND
$53.4K
4 donations
UPSTATE VICTORY FUND
$46.2K
2 donations
WIN NEW YORK VICTORY FUND
$28.0K
2 donations
DEMOCRACY ACTION NOW NEW YORK
$24.2K
1 donation
DEMOCRACY SUMMER 2024
$20.0K
1 donation
END CITIZENS UNITED - PRIORITY 2024 - UNITEMIZED
$15.5K
1 donation
END CITIZENS UNITED - PRIORITY 2024
$15.0K
1 donation
AMERICAN ISRAEL PUBLIC AFFAIRS COMMITTEE POLITICAL ACTION COMMITTEE
$13.2K
2 donations
Senate LDA filings that name a bill Patrick Ryan sponsored and report on lobbying during that bill's Congress. A filing that names a bill shows the registrant lobbied on it, not contact with Ryan or the office.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
via PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
$7.6M
2025Q2
CHARTER COMMUNICATIONS INC
via CHARTER COMMUNICATIONS, INC.
$2.6M
2025Q2
AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA)
via AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA)
$10.0K
2025Q2
NCTA - THE INTERNET & TELEVISION ASSOCIATION
via NCTA - THE INTERNET & TELEVISION ASSOCIATION
$3.1M
2025Q2
PUBLIC CITIZEN
via PUBLIC CITIZEN
$98.8K
2025Q2
COMMUNITY ASSOCIATIONS INSTITUTE
via COMMUNITY ASSOCIATIONS INSTITUTE
$30.0K
2025Q2
GSK (FKA GLAXOSMITHKLINE INC.)
via GSK (FKA GLAXOSMITHKLINE INC.)
$1.5M
2025Q2
FOX CORPORATION
via FOX CORPORATION
$1.3M
2025Q2
CHARTER COMMUNICATIONS INC
via CHARTER COMMUNICATIONS, INC.
$2.7M
2025Q1
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
via PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
$12.9M
2025Q1
The 10 most recent of 15 filings, across 3 sponsored bills. The amount is what the registrant reported for the whole filing, not spending on this bill. Every filing is in the newsroom bundle with its LDA link.
| Date | Question | Bill | Position | Result |
|---|---|---|---|---|
| Jul 23, 2026 | On Passage | nay | Passed | |
| Jul 23, 2026 | On Agreeing to the Resolution | yea | Passed | |
| Jul 22, 2026 | On Agreeing to the Resolution | nay | Passed | |
| Jul 22, 2026 | On Passage | nay | Passed | |
| Jul 22, 2026 | On Motion to Recommit | yea | Failed | |
| Jul 22, 2026 | On Passage | nay | Passed | |
| Jul 22, 2026 | On Motion to Recommit | yea | Failed | |
| Jul 22, 2026 | On Agreeing to the Amendment | nay | Failed | |
| Jul 22, 2026 | On Agreeing to the Amendment | nay | Agreed to | |
| Jul 22, 2026 | On Agreeing to the Amendment | nay | Failed | |
| Jul 22, 2026 | On Agreeing to the Amendment | nay | Agreed to | |
| Jul 21, 2026 | On Passage | nay | Passed | |
| Jul 21, 2026 | On Passage | nay | Passed | |
| Jul 21, 2026 | On Motion to Recommit | yea | Failed | |
| Jul 21, 2026 | On Agreeing to the Amendment | nay | Failed | |
| Jul 21, 2026 | On Agreeing to the Amendment | nay | Agreed to | |
| Jul 21, 2026 | On Agreeing to the Amendment | not_voting | Agreed to | |
| Jul 21, 2026 | On Agreeing to the Amendment | nay | Failed | |
| Jul 21, 2026 | On Agreeing to the Amendment | nay | Agreed to | |
| Jul 21, 2026 | On Agreeing to the Amendment | nay | Failed |
A bill number appears where the roll call names a measure. Procedural votes — motions to recommit, resolutions on the rule, adjournment — often name none, and the House Clerk's record for 2026 is still being matched to bills.